David Liu unlocks the power of gene editing to treat rare genetic diseases
Base and prime gene-editing technologies can precisely correct genetic mutations, enabling personalized therapies that can cure life-threatening inherited diseases.
Pioneering new treatment reverses incurable blood cancer in some patients
Base editing of patients' white blood cells can reverse aggressive, treatment-resistant T-cell acute lymphoblastic leukaemia, achieving remission in about 64% of treated cases.
